Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K23DK082638-04 | U.S. NIH Grant/Contract | View source | |
| 22275 | Other Identifier | University of Minnesota |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise | Experimental | blended supervised-hombased exercise training 3-4 times/week for 12 weeks |
|
| control | No Intervention | control group asked to continue usual activities |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise | Behavioral | Blended supervised-home based walking program 3-4 times per week for at least 30 minutes. |
|
| Measure | Description | Time Frame |
|---|---|---|
| endothelial function measured by brachial artery flow mediated vasodilation | Endothelium-mediated change in in vascular tone | at week 0 and at week 12 |
| Measure | Description | Time Frame |
|---|---|---|
| arterial stiffness measured by pulse wave velocity | at week 0 and at week 12 | |
| Circulating markers of vascular health | C-reactive protein, isoprostane F2, Asymmetric dimethylarginine | at week 0 and at week 12 |
Not provided
Inclusion Criteria:
Have diagnosed type 2 diabetic mellitus by one of the following criteria:
o Treated with diet, diet plus oral hypoglycemic agents (for at least one year), or insulin preceded by treatment with oral agents (for at least one year).
If treated with insulin, the onset of diabetes must have occurred after age of 40 and the body mass index must be >25kg/m2 at the time of diagnosis.
Diagnosed kidney attributed to diabetes by one of the following criteria:3
Macroalbuminuria (ACR >300mg/g, or)
Microalbuminuria (ACR between 30-300 mg/g) or in the presence of diabetic retinopathy (although is recognized that about 1/3 of type 2 diabetics do not have retinopathy by fundoscopic exam).
An elevated ACR should have been confirmed in the absence of urinary tract infections with 2 additional first-void specimens collected over 3-6 months.
At least 2 of 3 samples should fall within the range of micro or macroalbuminuria.
Exclusion Criteria:
• Patients are currently exercising
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ulf G Bronas, PhD | University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 | United States |
Not provided
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D003928 | Diabetic Nephropathies |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| aerobic capacity | Peak oxygen consumption | at week 0 and at week 12 |
| blood pressure | at week 0 and at week 12 |
| 24-hour albuminuria | assessed in 30 participants measured in milligram per gram creatinine | at week 0 and at week 12 |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D048909 | Diabetes Complications |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |